Pharma Journalist - Page 680 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

FDA to evaluate sBLA of DUPIXENT for Asthama patients

Mylan set to introduce viable HIV treatments, Symfi Lo and Cimduo

FDA approves Jazz Pharmaceutical’s NDA for solriamfetol in OSA patients

Concert Pharmaceuticals proclaims facilitation of Candidate CTP-692 in Schizophrenia

FDA finalizes Booz Allen for Spot on $300M Award to optimize DRM

Apnea Sciences Corporation launched SnoreRx as approved by FDA